Quantitative Analysis of Cannabinoids in W hole Blood Using UPLC-MS/MS for Forensic Laboratories

Importance of the Topic

Whole blood analysis of psychoactive cannabinoids is a cornerstone in forensic and roadside testing. Monitoring delta9 tetrahydrocannabinol and its major metabolites provides direct evidence of recent cannabis exposure and potential impairment.

Study Objectives and Overview

This work aimed to develop and validate a quantitative UPLC MS MS method for THC, THC OH and THC COOH in minimal volumes of whole blood. The protocol seeks to eliminate derivatization, shorten run times and boost sample throughput compared to traditional GC MS MS approaches.

Materials and Methods

Calibration standards and deuterated internal standards were prepared in methanol and spiked into blank whole blood. Samples underwent protein precipitation with acetonitrile followed by mixed mode solid phase extraction. Chromatography employed a C18 column with an aqueous formic acid and acetonitrile gradient at 400 microliters per minute. Detection was performed on a triple quadrupole mass spectrometer in positive electrospray multiple reaction monitoring mode. Data processing used TargetLynx with 1 over x weighting for calibration.

Instrumentation

• ACQUITY UPLC System
• Xevo TQ S mass spectrometer
• ACQUITY UPLC BEH C18 column
• Oasis MAX solid phase extraction cartridge
• MassLynx software with TargetLynx

Main Results and Discussion

Retention time and ion ratio criteria ensured unambiguous analyte identification. Calibration over 0.5 to 50 ng per mL yielded correlation coefficients above 0.995. Limits of detection ranged from 0.05 to 0.15 ng per mL, and lower limits of quantification from 0.15 to 0.25 ng per mL. Matrix effects were minimal and recoveries between 55 and 80 percent. Inter day accuracy and precision across three QC levels met acceptance criteria within twenty percent bias and RSD. Extracted sample stability remained constant over twenty four hours and carryover was negligible. In authentic sample analysis, THC COOH was detected in all positive samples, with strong correlation to a reference GC MS MS method (r squared up to 0.996).

Benefits and Practical Applications

• Reduced sample volume down to 0.2 mL
• No derivatization step
• Short analytical cycle of approximately 6.5 minutes
• Enhanced throughput and sensitivity
• Ideal for high volume forensic testing

Future Trends and Applications

Advances may include further miniaturization of sample preparation, integration with automated platforms and expansion to broader analyte panels. Point of care testing solutions and application of machine learning to data interpretation are expected to drive future forensic toxicology innovation.

Conclusion

The validated UPLC MS MS workflow offers accurate, rapid and low volume quantitation of cannabinoids in whole blood, matching established GC MS MS results while delivering superior speed and simplicity for routine forensic laboratories.

References

1. Dewey WL Cannabinoid pharmacology Pharmacological Review 1986 38 151
2. Musshoff F Madea B Review of biologic matrices as indicators of cannabis use Therapeutic Drug Monitoring 2006 28 155 163
3. Huestis M et al Blood cannabinoids absorption of THC and metabolites J Analytical Toxicology 1992 16 276 282
4. Scurlock R et al Detection of THC and THCA in whole blood using GC MS J Analytical Toxicology 2006 30 262 266
5. Chu M Drummer O Determination of THC in whole blood using GC MS J Analytical Toxicology 2002 26 575 581
6. Lacroix C Saussereau E Fast LC MS MS determination of cannabinoids after derivatization J Chromatography B 2012 905 85 95
7. Jamey C et al Determination of cannabinoids in whole blood by UPLC MS MS J Analytical Toxicology 2008 32 349 354
8. Young MS Martin JT Optimized SPE for UPLC MS MS and GC MS MS determination of THC in blood Waters Application Note 2010